Clinical Trials Search at Vanderbilt-Ingram Cancer Center

An Open-Label, Phase 1a/1b, Dose Escalation and Dose Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PHST001 in Adult Patients with Advanced Relapsed and/or Refractory Solid Tumors

Disease Sites:

Miscellaneous

Staging:

Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

PHST001

Principal Investigator(s):

Davis, Elizabeth

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

09-24-2025

Trial Type:

Treatment

Protocol ID:

VICCPHI24591

National Clinical Trial ID:

NCT06840886

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available